Cargando…
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic relapsing disease in gastrointestinal tract. Conventional medications lack the efficacy to offer complete remission in IBD therapy, and usually associate with serious side effects. Recent studies indicated that nanoparticle-based nanotherapeutics may off...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016370/ https://www.ncbi.nlm.nih.gov/pubmed/27678353 http://dx.doi.org/10.3748/wjg.v22.i34.7718 |